Wedemeier Rodney
Known title: CHROCIK: 0002091997
Associated companies
Transaction History
| VSTS | ▲ Buy | Grant | 21,038 | $0 | 12/9/2025 | View on chart |
| VSTS | ▲ Buy | Grant | 66,667 | $0 | 11/1/2025 | View on chart |
| VSTS | ▲ Buy | Grant | 21,038 | $0 | 12/9/2025 | View on chart |
| VSTS | ▲ Buy | Grant | 66,667 | $0 | 11/1/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Vestis Names New CFO, Could Alter Turnaround Strategy
Vestis Corporation has appointed a new chief financial officer, a move that may change the company’s approach to its turnaround plan. The hire signals a possible shift in how the firm will manage costs and growth, which could affect its financial outlook. The stock is trading near a key support level of $12.78, and analysts expect a target of $13.00 on average. This development is noteworthy for stakeholders watching the company’s recovery path.
Vestis Names New CFO, Could Alter Turnaround Strategy. Vestis Corporation has appointed a new chief financial officer, a move that may change the company’s approach to its turnaround plan. The hire signals a possible shift in how the firm will manage costs and growth, which could affect its financial outlook. The stock is trading near a key support level of $12.78, and analysts expect a target of $13.00 on average. This development is noteworthy for stakeholders watching the company’s recovery path.